Implications for function and therapy of a 2.9 Å structure of binary-complexed antithrombin

Journal of Molecular Biology

Volumn 283, Issue 1, 1998, Pages 9-14

  Skinner, Richard ^a,c   Chang, Wun Shaing W ^a,b,d   Jin, Lei ^a   Pei, Xue ^a   Huntington, James A ^a   Abrahams, Jan Pieter ^e   Carrell, Robin W ^a   Lomas, David A ^a,b  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c UNILEVER RESEARCH   (United Kingdom)

^d INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

^e NONE

Author keywords

Peptide; Polymerisation; Serpin; 1 antitrypsin

Indexed keywords

ANTITHROMBIN; HEPARIN; SERINE PROTEINASE INHIBITOR;

AMINO ACID SEQUENCE; ARTICLE; CRYSTAL STRUCTURE; DRUG DESIGN; POLYMERIZATION; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN DEGRADATION; PROTEIN SECONDARY STRUCTURE; PROTEIN STRUCTURE;

EID: 0032538299     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmbi.1998.2083     Document Type: Article

References (33)

1. 436 → Thr) results in nonsubstrate-like behavior and in polymerization of the molecule. J. Biol. Chem. 268, 18088-18094.
2. Björk, I., Ylinenjärvi, K., Olson, S. T. & Bock, P. E. (1992). Conversion of antithrombin from an inhibitor of thrombin to a substrate with reduced heparin affinity and enhanced conformational stability by binding of a tetradecapeptide corresponding to the P1-P14 region of the putative reactive bond loop of the inhibitor. J. Biol. Chem. 267, 1976-1982.
3. Bruce, D., Perry, D. J., Borg, J.-Y., Carrell, R. W. & Wardell, M. R. (1994). Thromboembolic disease due to thermolabile conformational changes of antithrombin Rouen VI (187 Asn → Asp). J. Clin. Invest. 94, 2265-2274.
4. Carrell, R. W., Stein, P. E., Fermi, G. & Wardell, M. R. (1994). Biological implications of a 3 Å structure of dimeric antithrombin. Structure, 2, 257-270.
5. Chang, W.-S. W., Wardell, M. R., Lomas, D. A. & Carrell, R. W. (1996). Probing serpin reactive loop conformations by proteolytic cleavage. Biochem. J. 314, 647-653.
6. Collaborative Computational Project Number 4 (1994). Programs for protein crystallography. Acta Crystallog. sect. D, 50, 760-763.
7. Eldering, E., Verpy, E., Roem, D., Meo, T. & Tosi, M. (1995). COOH-terminal substitutions in the serpin Cl inhibitor that cause loop overinsertion and subsequent multimerization. J. Biol. Chem. 270, 2579-2587.
8. 1-antitrypsin. Nature Struct. Biol. 3, 676-681.
9. 1-antitrypsin is in the canonical inhibitory conformation. J. Mol. Biol. 275, 419-425.
10. Fitton, H. L., Pike, R. N., Carrell, R. W. & Chang, W.-S. W. (1997). Mechanisms of antithrombin polymerisation and heparin activation probed by insertion of synthetic reactive loop peptides. Biol. Chem. 378, 1059-1063.
11. Huntington, J. A. & Gettins, P. G. W. (1998). Conformational conversion of antithrombin to a fully activated substrate of factor Xa without need for heparin. Biochemistry, 37, 3272-3277.
12. Huntington, J. A., Olson, S. T., Fan, B. & Gettins, P. G. W. (1996). Mechanism of heparin activation of antithrombin. Evidence for reactive center loop preinsertion with expulsion upon heparin binding. Biochemistry, 35, 8495-8503.
13. Jin, L., Abrahams, J.-P., Skinner, R., Petitou, M., Pike, R. & Carrell, R. W. (1997). The anticoagulant activation of antithrombin by heparin. Proc. Natl Acad. Sci. USA, 94, 14683-14688.
14. Jones, T. A., Zou, J.-Y., Cowan, S. W. & Kjeldgaard, M. (1991). Improved methods for building protein models in electron density maps and the location of errors in these models. Acta Crystallog. sect. A, 47, 110-119.
15. Kraulis, P. J. (1991). MOLSCRIPT: a program to produce both detailed and schematic plots of protein structures. J. Appl. Crystallog. 24, 946-950.
16. Laskowski, R. A., MacArthur, M. W., Moss, D. S. & Thornton, J. M. (1994). PROCHECK: a program to check the stereo chemical quality of protein structures. J. Appl. Crystallog. 26, 283-291.
17. Leslie, A. W. G. (1992). In Joint CCP4 and ESF-EACMB Newsletter on Protein Crystallography, vol. 26, Daresbury Laboratory, Warrington, UK.
18. 1-proteinase inhibitor. Crystal structure analysis of two crystal modifications, molecular model and preliminary analysis of the implications for function. J. Mol. Biol. 177, 531-556.
19. 1-antitrypsin accumulation in the liver. Nature, 357, 605-607.
20. 1-anti-trypsin. Biochemistry, 32, 500-508.
21. 1-proteinase inhibitor probed by limited proteolysis. Biochemistry, 31, 2720-2728.
22. Navaza, J. (1994). AMoRe: an automated package for molecular replacement. Acta Crystallog. sect. A, 50, 157-163.
23. Nicholls, A. (1992). GRASP: graphical representation and analysis of surface properties, Columbia University, New York.
24. Olson, S. T., Björk, I., Sheffer, R., Craig, P. A., Shore, J. D. & Choay, J. (1992). Role of antithrombin-binding pentasaccharide in heparin acceleration of antithrombin-proteinase reactions. J. Biol. Chem. 267, 12528-12538.
25. Olson, S. T., Björk, I. & Shore, J. D. (1993). Kinetic characterization of heparin-catalyzed and uncatalyzed inhibition of blood coagulation proteinases by antithrombin. Methods Enzymol. 524, 525-559.
26. Pike, R. N., Potempa, J., Skinner, R., Fitton, H. L., McGraw, W. T., Travis, J., Owen, M., Jin, L. & Carrell, R. W. (1997). Heparin-dependent modification of the reactive center arginine of antithrombin and consequent increase in heparin binding affinity. J. Biol. Chem. 272, 19652-19655.
27. Read, R. J. (1986). Improved Fourier coefficients for maps using phases from partial structures with errors. Acta Crystallog. sect. A, 42, 140-149.
28. Schreuder, H. A., de Boer, B., Dijkema, R., Mulders, J., Theunissen, H. J. M., Grootenhuis, P. D. J. & Hol, W. G. J. (1994). The intact and cleaved human antithrombin III complex as a model for serpin-proteinase interactions. Nature Struct. Biol. 1, 48-54.
29. 1-antitrypsin by a peptide sequentially similar to β-strand s4A. Eur. J. Biochem. 194, 51-56.
30. 1 proteinase inhibitor in β-sheet A. Biochemistry, 31, 7560-7565.
31. Skinner, R., Abrahams, J.-P., Whisstock, J. C., Lesk, A. M., Carrell, R. W. & Wardell, M. R. (1997). The 2.6 A structure of antithrombin indicates a conformational change at the heparin binding site. J. Mol. Biol. 266, 601-609.
32. Tronrud, D. E., Ten, Eyck L. F. & Matthews, B. W. (1992). An efficient general-purpose least-squares refinement program for macromolecular structures. Acta Crystallog. sect. A, 43, 489-501.
33. van Boeckel, C. A. A., Grootenhuis, P. D. J. & Visser, A. (1994). A mechanism for heparin-induced potentiation of antithrombin III. Nature Struct. Biol. 1, 423-425.